A carregar...
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Immune checkpoint blockade (ICB) therapies, which potentiate the body’s natural immune response against tumor cells, have shown immense promise in the treatment of various cancers. Currently, tumor mutational burden (TMB) and programmed death ligand 1 (PD-L1) expression are the primary biomarkers ev...
Na minha lista:
| Publicado no: | Genome Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6264032/ https://ncbi.nlm.nih.gov/pubmed/30497521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0605-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|